Medical Marijuana for Peripheral Neuropathy

What is Peripheral Neuropathy?

Peripheral neuropathy is damage to or dysfunction of the peripheral nervous system (nerves outside the brain and spinal cord). Common causes include diabetes mellitus, chemotherapy, HIV infection, alcohol use, autoimmune disease, vitamin deficiency, infection, trauma, and inherited disorders. Symptoms typically include burning or shooting pain, tingling, numbness, weakness, and loss of coordination, most often in a stocking-glove distribution affecting feet first and then hands.

Does cannabis help Peripheral Neuropathy?

The 2017 NASEM consensus report identified substantial evidence that cannabis is an effective treatment for chronic pain in adults. Peripheral neuropathy is a major chronic-pain subtype and was specifically included in several of the controlled trials that informed the NASEM finding.

Notable trial evidence includes:

• HIV-associated peripheral neuropathy: controlled trials of smoked cannabis (early 2000s) demonstrated pain reduction relative to placebo.
• Diabetic peripheral neuropathy: smaller controlled trials of inhaled and sublingual cannabinoids have shown pain reduction with dose-response patterns.
• Chemotherapy-induced peripheral neuropathy: observational and small-trial data are consistent with pain reduction; dedicated CIPN trials are sparse.

Both THC-dominant and CBD-dominant formulations have been studied, with mixed evidence on the relative contribution of each cannabinoid. Most positive trials have used preparations containing at least some THC.

Practical considerations

Cannabis is typically used adjunctively alongside standard neuropathic-pain therapy (gabapentin, pregabalin, duloxetine, tricyclics, topical agents). Patients should coordinate cannabis use with their neurologist, endocrinologist (for diabetic neuropathy), oncologist (for CIPN), or pain-management physician.

Drug interactions include additive CNS depression with gabapentinoids, opioids, and tricyclics. Cannabis may interact with warfarin and some antiretrovirals through CYP450 effects; patients on these medications should coordinate with their prescriber.

Important: peripheral neuropathy may signal underlying conditions (uncontrolled diabetes, B12 deficiency, autoimmune disease) that require disease-modifying treatment. Cannabis use should not substitute for evaluation and treatment of the underlying cause.